The US Food and Drug Administration (FDA) has updated its quarterly watch list with four dozen drugs and drug classes because it has received new safety information or identified possible signs of serious risk — including serious risks from conditions such as Anaphylaxis, Herpes Zoster, and Fetal Death.
FDA Watch List Adds Drugs with Risk of Anaphylaxis, Herpes Zoster and Fetal Death Risk
COVID-19 Preparedness Checklist for Nursing Homes and other Long-Term Care Settings
Through client communications, Empirian Health has learned of multiple facilities’ recent survey experiences. According to the facilities, survey teams are utilizing the COVID-19 Preparedness Checklist…
CDC releases updated consolidated testing guidelines for nursing homes
On June 13, 2020, the Centers for Disease Control and Prevention released consolidated recommendations for COVID-19 testing, which included revisions to the testing guidelines for nursing…
CMS issues a Nursing Homes Best Practices Toolkit to Combat COVID-19
On May 13, 2020, CMS released a new toolkit developed to aid nursing homes, governors, states, departments of health, and other agencies who provide oversight…
Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment
The Emergency Use Authorization (EUA) allows Remdesivir to be administered intravenously to treat both children and adults hospitalized with suspected or laboratory-confirmed COVID-19 and severe…
